Xcel Brands, Inc. Announces Proposed Public Offering of Common Stock
March 14, 2024 16:10 ET
|
Xcel Brands, Inc
NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (“Xcel”; NASDAQ: XELB), a media and consumer products company engaged in the design, licensing, marketing, live streaming and social...
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
March 11, 2024 16:05 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N. Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed...
ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
March 06, 2024 16:17 ET
|
ADT Inc.
ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
SolarMax Technology, Inc. Announces Exercise of Overallotment Option From Initial Public Offering
March 05, 2024 16:01 ET
|
SolarMax Technology, Inc.
RIVERSIDE, CA, March 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SolarMax Technology, Inc. (“SolarMax” or the “Company”) (Nasdaq SMXT), an integrated solar energy company, announced today that...
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 05, 2024 10:10 ET
|
Celldex Therapeutics, Inc.
HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public...
Agrify Corporation Announces CEO Participation in Closing of Public Offering
March 05, 2024 08:00 ET
|
Agrify
Agrify Corporation Announces CEO Participation in Closing of Public Offering
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
March 04, 2024 23:42 ET
|
iRhythm
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect,...
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
March 04, 2024 16:17 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers,...
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
February 29, 2024 21:18 ET
|
Humacyte, Inc.
DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at...
SolarMax Technology, Inc. Announces Closing of Initial Public Offering
February 29, 2024 13:30 ET
|
SolarMax Technology, Inc.
RIVERSIDE, CA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SolarMax Technology, Inc. (“SolarMax” or the “Company”) (Nasdaq: SMXT), an integrated solar energy company, today announced the...